Skip to content

The effct of intraperitoneal chemotherapy (IPC) with lobaplatin on early postoperative hyperalgesia in patients underwent elective laparoscopic transabdominal radical resection of rectal cancer

The effct of intraperitoneal chemotherapy (IPC) with lobaplatin on early postoperative hyperalgesia in patients underwent elective laparoscopic transabdominal radical resection of rectal cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010915
Enrollment
Unknown
Registered
2017-03-18
Start date
2017-03-18
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

group L:single administration of lobaplatin
group C:single administration of glucose

Sponsors

Liaocheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
46 Years to 65 Years

Inclusion criteria

Inclusion criteria: All subjects presenting for elective laparoscopic transabdominal radical resection of rectal cancer were included in the data analysis. Inclusion criteria included an ASA physical status of I, II or III, aged 46–65 years, body mass index less than or equal to 30.

Exclusion criteria

Exclusion criteria: Exclusion criteria included contraindications to post-operative patient-controlled analgesia (PCA), allergy to sufentanil, allergy to lobaplatin, history of sinus bradycardia or AVB, history of major psychiatric disorder, history of substance use disorder, current opioid use and history of chronic pain.

Design outcomes

Primary

MeasureTime frame
sufentanil requirement;

Secondary

MeasureTime frame
NRS;FAS;

Countries

China

Contacts

Public ContactMin Liang

Liaocheng People's Hospital

liangmin861016@163.com+86 15163511260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026